XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Retained Deficit
Accumulated Other Comprehensive (Loss) Income
Total
Balance at beginning of period at Dec. 31, 2019 $ 233 $ 154,235 $ (49,731) $ (1,572) $ 103,165
Balance at beginning of period (in shares) at Dec. 31, 2019 23,335,855        
Increase (Decrease) in Stockholders' Equity          
Net (loss) income     993   993
Unrealized income (loss) on foreign exchange rate translation       (1,199) (1,199)
Stock-based compensation expense   203     203
Balance at end of period at Mar. 31, 2020 $ 233 154,438 (48,738) (2,771) 103,162
Balance at end of period (in shares) at Mar. 31, 2020 23,335,855        
Balance at beginning of period at Dec. 31, 2019 $ 233 154,235 (49,731) (1,572) 103,165
Balance at beginning of period (in shares) at Dec. 31, 2019 23,335,855        
Increase (Decrease) in Stockholders' Equity          
Net (loss) income         2,493
Balance at end of period at Jun. 30, 2020 $ 234 154,691 (47,238) (2,167) 105,520
Balance at end of period (in shares) at Jun. 30, 2020 23,399,035        
Balance at beginning of period at Mar. 31, 2020 $ 233 154,438 (48,738) (2,771) 103,162
Balance at beginning of period (in shares) at Mar. 31, 2020 23,335,855        
Increase (Decrease) in Stockholders' Equity          
Net (loss) income     1,500   1,500
Unrealized income (loss) on foreign exchange rate translation       604 604
Issuance of common stock under stock compensation plans $ 1 (1)      
Issuance of common stock under stock compensation plans (in shares) 78,600        
Stock-based compensation expense   271     271
Shares exchanged for taxes on stock-based compensation   (17)     (17)
Shares exchanged for taxes on stock-based compensation (in shares) (15,420)        
Balance at end of period at Jun. 30, 2020 $ 234 154,691 (47,238) (2,167) 105,520
Balance at end of period (in shares) at Jun. 30, 2020 23,399,035        
Balance at beginning of period at Dec. 31, 2020 $ 235 154,866 (62,927) (1,200) $ 90,974
Balance at beginning of period (in shares) at Dec. 31, 2020 23,526,517       23,478,072
Increase (Decrease) in Stockholders' Equity          
Net (loss) income     (5,228)   $ (5,228)
Unrealized income (loss) on foreign exchange rate translation       201 201
Stock-based compensation expense   101     101
Balance at end of period at Mar. 31, 2021 $ 235 154,967 (68,155) (999) 86,048
Balance at end of period (in shares) at Mar. 31, 2021 23,526,517        
Balance at beginning of period at Dec. 31, 2020 $ 235 154,866 (62,927) (1,200) $ 90,974
Balance at beginning of period (in shares) at Dec. 31, 2020 23,526,517       23,478,072
Increase (Decrease) in Stockholders' Equity          
Net (loss) income         $ (14,245)
Balance at end of period at Jun. 30, 2021 $ 237 154,987 (77,172) (788) $ 77,264
Balance at end of period (in shares) at Jun. 30, 2021 23,680,427       23,631,982
Balance at beginning of period at Mar. 31, 2021 $ 235 154,967 (68,155) (999) $ 86,048
Balance at beginning of period (in shares) at Mar. 31, 2021 23,526,517        
Increase (Decrease) in Stockholders' Equity          
Net (loss) income     (9,017)   (9,017)
Unrealized income (loss) on foreign exchange rate translation       211 211
Issuance of common stock under stock compensation plans $ 2 (2)      
Issuance of common stock under stock compensation plans (in shares) 174,000        
Stock-based compensation expense   67     67
Issuance of common stock as compensation   30     30
Issuance of common stock as compensation (in shares) 11,320        
Shares exchanged for taxes on stock-based compensation   (75)     (75)
Shares exchanged for taxes on stock-based compensation (in shares) (31,410)        
Balance at end of period at Jun. 30, 2021 $ 237 $ 154,987 $ (77,172) $ (788) $ 77,264
Balance at end of period (in shares) at Jun. 30, 2021 23,680,427       23,631,982